In the latest quarter, 7 analysts provided ratings for Exact Sciences (NASDAQ:EXAS), showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $77.0, along with a high estimate of $85.00 and a low estimate of $67.00. Highlighting a 7.78% decrease, the current average has f…